Putnam Investments’s Transmedics TMDX Stock Holding History

Putnam Investments’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-87,230	Closed	-$4.78M	–	1223
2023 Q3	$4.78M	Sell	87,230 -8,015	-8%	-$577K	0.01%	440
2023 Q2	$8M	Buy	95,245 +68,069	+250%	+$5.21M	0.01%	355
2023 Q1	$2.06M	Sell	27,176 -9,695	-26%	-$670K	﹤0.01%	722
2022 Q4	$2.28M	Buy	+36,871	New	+$1.96M	﹤0.01%	695

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Putnam Investments's TMDX Position: Q4 2023 in Review

Putnam Investments sold out of Transmedics (TMDX) in Q4 2023, closing a stake of 87,230 shares — an estimated $4.78M sold.

Putnam Investments first reported a position in TMDX in Q4 2022 and held it in 4 quarters. The position peaked at $8M in Q2 2023. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

Putnam Investments reported no remaining Transmedics position as of Q4 2023 after selling out during the quarter.
Putnam Investments sold 87,230 Transmedics shares in Q4 2023, an estimated $4.78M.
Putnam Investments first reported a position in Transmedics in Q4 2022 and held it in 4 quarters.
Putnam Investments's Transmedics position peaked at $8M in Q2 2023.
248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.